Clerk of the House of Representatives
Legislative Resource Center
135 Cannon Building
Washington, DC 20515
http://lobbyingdisclosure.house.gov 		Secretary of the Senate
Office of Public Records
232 Hart Building
Washington, DC 20510
http://www.senate.gov/lobby
LOBBYING REPORT

Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page

1. Registrant Name Organization/Lobbying Firm Self Employed Individual
MEDICAL GROUP MANAGEMENT ASSN

2. Address

Address1
1717 PENNSYLVANIA AVENUE, NW
 Address2
​
City
WASHINGTON
 State
DC
 Zip Code
20006
 Country
USA

3. Principal place of business (if different than line 2)

City
​
State
​
Zip Code
​
Country
​
4a. Contact Name b. Telephone Number c. E-mail
​Mr.
​Anders Gilberg
​2022933450
​agilberg@mgma.com
5. Senate ID#
​24806-12
7. Client Name Self Check if client is a state or local government or instrumentality
​MEDICAL GROUP MANAGEMENT ASSN
6. House ID#
​336110000
TYPE OF REPORT 8. Year
​2025
 Q1 (1/1 - 3/31) Q2 (4/1 - 6/30) Q3 (7/1 - 9/30) Q4 (10/1 - 12/31)

9. Check if this filing amends a previously filed version of this report

10. Check if this is a Termination Report Termination Date
​
11. No Lobbying Issue Activity
INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13
12. Lobbying 13. Organizations
INCOME relating to lobbying activities for this reporting period was: EXPENSE relating to lobbying activities for this reporting period were:
Less than $5,000
Less than $5,000
$5,000 or more $
​
$5,000 or more $
​300,000.00
Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options.
Method A. Reporting amounts using LDA definitions only

Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code

Method C. Reporting amounts under section 162(e) of the Internal Revenue Code

Signature
Digitally Signed By: Anders Gilberg
Date
4/21/2025 1:27:09 PM

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code MMM

16. Specific lobbying issues

Medicare Payment - Supported the introduction of the Medicare Patient Access and Practice Stabilization Act (HR 879) to address the Medicare payment cut. Submitted letter to congressional leadership urging them to include a Medicare physician payment fix in government funding legislation and move towards a permanent payment solution as part of our 2025 legislative priorities. Joined two letters urging Congress to address the Medicare payment cut and move towards permanent reform in its appropriations bill.

Value-based care - Sent letter of support for the Preserving Patient Access to Accountable Care Act (HR 786) to extend value-based care policies that expired at the end of 2024. Pushed for the extension of the APM incentive payment and maintaining the QP thresholds to be included in the government funding bill as part of our letter to congressional leadership outlining our 2025 priorities.

Telehealth - Submitted a comment letter to the DEA on its proposed rule to establish a special registration process for prescribing controlled substances via telehealth. Joined letter urging Congress to establish permanent access to telehealth services. Pushed for an extension of telehealth flexibilities in a letter to congressional leadership outlining our 2025 priorities.

Prior authorization - Supported the reintroduction of the Reducing Medically Unnecessary Delays in Cares Act (HR 2433) to reform prior authorization, and joined a letter of support to the bill sponsors.

MIPS Value Pathways - Joined letter urging CMS to take an alternative approach to MIPS Value Pathways (MVPs).

Medicare Advantage - Joined a comment letter on CMS' proposed 2026 Policy and Technical Changes to the Medicare Advantage Program, Medicare Prescription Drug Benefit Program, Medicare Cost Plan Program, and Programs of All-Inclusive Care for the Elderly.

Health Information Technology - Submitted a comment letter and joined a letter urging HHS not to move forward with proposed changes to the HIPAA Security Rule. Joined letter highlighting the importance of the Assistant Secretary for Technology Policy/Office of the National Coordinator for Health Information Technology (ASTP/ONC).

17. House(s) of Congress and Federal agencies Check if None

U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Centers For Medicare and Medicaid Services (CMS), Health & Human Services - Dept of (HHS), Drug Enforcement Administration (DEA)

18. Name of each individual who acted as a lobbyist in this issue area

First Name Last Name Suffix Covered Official Position (if applicable) New
Anders
Gilberg
​
​
James
Haynes
​
​

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code HCR

16. Specific lobbying issues

Medicare Payment - Supported the introduction of the Medicare Patient Access and Practice Stabilization Act (HR 879) to address the Medicare payment cut. Submitted letter to congressional leadership urging them to include a Medicare physician payment fix in government funding legislation and move towards a permanent payment solution as part of our 2025 legislative priorities. Joined two letters urging Congress to address the Medicare payment cut and move towards permanent reform in its appropriations bill.

Value-based care - Sent letter of support for the Preserving Patient Access to Accountable Care Act (HR 786) to extend value-based care policies that expired at the end of 2024. Pushed for the extension of the APM incentive payment and maintaining the QP thresholds to be included in the government funding bill as part of our letter to congressional leadership outlining our 2025 priorities.

Telehealth - Submitted a comment letter to the DEA on its proposed rule to establish a special registration process for prescribing controlled substances via telehealth. Joined letter urging Congress to establish permanent access to telehealth services. Pushed for an extension of telehealth flexibilities in a letter to congressional leadership outlining our 2025 priorities.

Prior authorization - Supported the reintroduction of the Reducing Medically Unnecessary Delays in Cares Act (HR 2433) to reform prior authorization, and joined a letter of support to the bill sponsors.

MIPS Value Pathways - Joined letter urging CMS to take an alternative approach to MIPS Value Pathways (MVPs).

Medicare Advantage - Joined a comment letter on CMS proposed 2026 Policy and Technical Changes to the Medicare Advantage Program, Medicare Prescription Drug Benefit Program, Medicare Cost Plan Program, and Programs of All-Inclusive Care for the Elderly.

Health Information Technology - Submitted a comment letter and joined a letter urging HHS not to move forward with proposed changes to the HIPAA Security Rule. Joined letter highlighting the importance of the Assistant Secretary for Technology Policy/Office of the National Coordinator for Health Information Technology (ASTP/ONC).

17. House(s) of Congress and Federal agencies Check if None

U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Health & Human Services - Dept of (HHS), Centers For Medicare and Medicaid Services (CMS), Drug Enforcement Administration (DEA)

18. Name of each individual who acted as a lobbyist in this issue area

First Name Last Name Suffix Covered Official Position (if applicable) New
Anders
Gilberg
​
​
James
Haynes
​
​

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

Information Update Page - Complete ONLY where registration information has changed.

20. Client new address

Address
​
City
​
State
​
Zip Code
​
Country
​

21. Client new principal place of business (if different than line 20)

City
​
State
​
Zip Code
​
Country
​

22. New General description of client’s business or activities

​

LOBBYIST UPDATE

23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client

First Name
Last Name
Suffix
First Name
Last Name
Suffix
1
​
​
​
3
​
​
​
2
​
​
​
4
​
​
​

ISSUE UPDATE

24. General lobbying issue that no longer pertains

​
​
​
​
​
​
​
​
​

AFFILIATED ORGANIZATIONS

25. Add the following affiliated organization(s)

Internet Address:

Name Address Principal Place of Business
(city and state or country)
Street Address
City State/Province Zip Country
City
State Country

26. Name of each previously reported organization that is no longer affiliated with the registrant or client

1 2 3

FOREIGN ENTITIES

27. Add the following foreign entities:

Name Address Principal place of business
(city and state or country) 		Amount of contribution for lobbying activities Ownership percentage in client
Street Address
City State/Province Country
City
State Country
%

28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization

1 3 5
2 4 6

CONVICTIONS DISCLOSURE

29. Have any of the lobbyists listed on this report been convicted in a Federal or State Court of an offense involving bribery, extortion, embezzlement, an illegal kickback, tax evasion, fraud, a conflict of interest, making a false statement, perjury, or money laundering?

Lobbyist Name Description of Offense(s)